Last year the Swedish medicinal company Enorama Pharma got permission from the Swedish Medical Products Agency to import and handle cannabis. They are now developing their medical cannabis chewing gum for the rapidly expanding global market.
The Multiple Sclerosis Society of Canada is investing $1.5 million in a new, never before researched study. They are teaming up with the Canadian Institutes of Health Research to perform this research. The goal is to see if MS could be treated with cannabis.